Sunday, March 29, 2026

InMed's INM-901 demonstrates a multi-factorial approach to potentially treat Alzheimer's disease, including neuroprotective effects, an ability to extend the length of neurites, which is important for brain cell-to-cell communication, as well as a reduction in neuroinflammation.

https://x.com/inmedpharma/status/1881494018011599189 

No comments:

Post a Comment